Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Neostigmine for PDPH Prevention in C-section
NCT05289323Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Apr 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of neostigmine in post-dural puncture headache (PDPH), sponsored by Alexandria University. Started Apr 2022; status: completed.
02
Drugs
neostigmine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT05289323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289323.